These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 1700909)
1. Observations on the mechanism of action of FK-506. A pharmacologic probe of lymphocyte signal transduction. Sigal NH; Siekierka JJ; Dumont FJ Biochem Pharmacol; 1990 Nov; 40(10):2201-8. PubMed ID: 1700909 [No Abstract] [Full Text] [Related]
2. Early effects of the immunosuppressive drug FK-506 on signal transduction in lymphocytes. Doe SE; Benzie CR; Kay JE Biochem Soc Trans; 1990 Jun; 18(3):451-2. PubMed ID: 1695581 [No Abstract] [Full Text] [Related]
3. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Sigal NH; Dumont FJ Annu Rev Immunol; 1992; 10():519-60. PubMed ID: 1375473 [TBL] [Abstract][Full Text] [Related]
4. FK 506 and rapamycin: molecular probes of T-lymphocyte activation. Bierer BE; Jin YJ; Fruman DA; Calvo V; Burakoff SJ Transplant Proc; 1991 Dec; 23(6):2850-5. PubMed ID: 1721296 [No Abstract] [Full Text] [Related]
5. Inhibition of murine B-lymphocyte proliferation by the novel immunosuppressive drug FK-506. Walliser P; Benzie CR; Kay JE Immunology; 1989 Nov; 68(3):434-5. PubMed ID: 2480331 [TBL] [Abstract][Full Text] [Related]
6. Flow cytometric analysis of lymphocyte populations and activation antigen expression in blood and lymphoid tissues of FK 506-treated rats. Woo J; Ross CS; Milton JI; Thomson AW Transplant Proc; 1990 Aug; 22(4):1642-4. PubMed ID: 1697112 [No Abstract] [Full Text] [Related]
7. Effects of FK 506 and low concentration cyclosporine on human lymphocyte activation antigen expression: a flow cytometric analysis. Woo J; Sewell HF; Thomson AW Transplant Proc; 1990 Aug; 22(4):1645-6. PubMed ID: 1697113 [No Abstract] [Full Text] [Related]
8. Mechanisms of immunosuppression by FK506. Preservation of T cell transmembrane signal transduction. Bierer BE; Schreiber SL; Burakoff SJ Transplantation; 1990 Jun; 49(6):1168-70. PubMed ID: 1694317 [No Abstract] [Full Text] [Related]
9. The mechanism of action of the immunosuppressive drug FK-506. Kay JE; Doe SE; Benzie CR Cell Immunol; 1989 Nov; 124(1):175-81. PubMed ID: 2478301 [TBL] [Abstract][Full Text] [Related]
10. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells. Dumont FJ; Melino MR; Staruch MJ; Koprak SL; Fischer PA; Sigal NH J Immunol; 1990 Feb; 144(4):1418-24. PubMed ID: 1689353 [TBL] [Abstract][Full Text] [Related]
11. The mechanism of action of FK 506. Kay JE; Moore AL; Doe SE; Benzie CR; Schönbrunner R; Schmid FX; Halestrap AP Transplant Proc; 1990 Feb; 22(1):96-9. PubMed ID: 1689914 [No Abstract] [Full Text] [Related]
12. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice. Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187 [TBL] [Abstract][Full Text] [Related]
13. Effect of FK 506 on B-cell responses. Lagodziński Z; Górski A; Stepień-Sopniewska B; Wasik M Transplant Proc; 1991 Feb; 23(1 Pt 2):942-3. PubMed ID: 1703359 [No Abstract] [Full Text] [Related]
14. Signal transduction. Immunosuppressants at work. DeFranco AL Nature; 1991 Aug; 352(6338):754-5. PubMed ID: 1715515 [No Abstract] [Full Text] [Related]
15. Interspecies comparison of the immunosuppressive efficacy and safety of FK 506. Thomson AW Transplant Proc; 1990 Feb; 22(1):100-5. PubMed ID: 1689883 [No Abstract] [Full Text] [Related]
16. Inhibition of T and B lymphocyte proliferation by rapamycin. Kay JE; Kromwel L; Doe SE; Denyer M Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916 [TBL] [Abstract][Full Text] [Related]
17. Comparative immunoregulatory effects of rapamycin, FK 506 and cyclosporine on mitogen-induced cytokine production and lymphoproliferation. Wu J; Palladino MA; Figari IS; Morris RE Transplant Proc; 1991 Feb; 23(1 Pt 1):238-40. PubMed ID: 1703683 [No Abstract] [Full Text] [Related]
18. The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation. Bierer BE; Schreiber SL; Burakoff SJ Eur J Immunol; 1991 Feb; 21(2):439-45. PubMed ID: 1705513 [TBL] [Abstract][Full Text] [Related]
19. Development of a macromolecular prodrug of FK 506: II: In vitro study for FK 506-dextran conjugate. Yura H; Yoshimura N; Hamashima T; Oka T; Takakura Y; Hashida M Transplant Proc; 1998 Jun; 30(4):1031-2. PubMed ID: 9636416 [No Abstract] [Full Text] [Related]